# Intraosseous vs. Intravenous Vancomycin Prophylaxis for Diabetic Foot Amputations: A Randomized Trial

> **NCT07338773** · PHASE4 · RECRUITING · sponsor: **Başakşehir Çam & Sakura City Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Diabetic Foot Disease
- Diabetic Foot Infection
- Diabetic Amputation Foot Wound

## Interventions

- **DRUG:** Intraosseous Vancomycin
- **DRUG:** Intravenous Vancomycin

## Key facts

- **NCT ID:** NCT07338773
- **Lead sponsor:** Başakşehir Çam & Sakura City Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-03
- **Primary completion:** 2026-05-04
- **Final completion:** 2026-06-19
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07338773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07338773, "Intraosseous vs. Intravenous Vancomycin Prophylaxis for Diabetic Foot Amputations: A Randomized Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07338773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*